72.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
72.2.0.1 ð Cram Sheet
72.2.0.1.1 ð¥ é« yield 12ïŒäºæŽ²æçŸ€å¿ èïŒ
- **HLA-B*1502 + carbamazepine** â SJS/TENïŒå°ç£ 8-12%ïŒ
- **HLA-B*5801 + allopurinol** â SJS/TEN/DRESSïŒæŒ¢æ 10-20%ïŒ
- **HLA-B*5701 + abacavir** â HSRïŒuniversalïŒ
- CYP2C19 + clopidogrel â LoF â stent thrombosisïŒäºæŽ² 25-30%ïŒ
- TPMT / NUDT15 + thiopurine â myelosuppressionïŒäºæŽ² NUDT15 éèŠïŒ
- VKORC1/CYP2C9 + warfarin â INR variability
- CYP2D6 + codeine UM â opioid toxicity / PM â ç¡æ
- DPYD + 5-FU/capecitabine â severe toxicity
- UGT1A1 + irinotecan â diarrhea/neutropenia
- G6PD + primaquine/dapsone/sulfa â hemolysis
- CPIC guidelines = clinical åè
- Taiwan å¥ä¿: HLA-B*1502 carbamazepineïŒ2010+ïŒ
72.2.0.1.2 ð¢ å¿ è
| åºå | è¥ | åæ |
|---|---|---|
| HLA-B*1502 | Carbamazepine, oxcarbazepine, phenytoin | SJS/TEN |
| HLA-B*5801 | Allopurinol | SJS/TEN/DRESS |
| HLA-B*5701 | Abacavir | HSR |
| CYP2C19 LoF | Clopidogrel | Stent thrombosis |
| TPMT/NUDT15 LoF | Azathioprine, 6-MP | Myelosuppression |
| VKORC1, CYP2C9 | Warfarin | INR variability |
| CYP2D6 UM | Codeine | Opioid toxicity |
| DPYD LoF | 5-FU, capecitabine | Severe toxicity |
| UGT1A1*28 | Irinotecan | Diarrhea, neutropenia |
| G6PD | Primaquine, dapsone | Hemolysis |
72.2.0.2 â é« yield
72.2.0.2.1 Asian Pharmacogenomics éé»
- HLA-B*1502 carbamazepineïŒå°ç£å¥ä¿ 2010+ïŒ
- HLA-B*5801 allopurinolïŒå¥ä¿éšåæ å¢ïŒ
- NUDT15 thiopurineïŒäºæŽ² > TPMTïŒ
- CYP2C19 LoF 髿¯äŸ (25-30%)
72.2.0.2.2 Codeine + CYP2D6
- UM = ultra-rapid metabolizer â éé morphine â respiratory depression
- PM = poor metabolizer â ç¡ morphine â ç¡é®ç
- FDA çŠ < 12 yo + æ çš lactating women
72.2.0.2.3 Tamoxifen + CYP2D6
- Tamoxifen â endoxifen (active) via CYP2D6
- PM â endoxifen äœ â æ²»ç倱æ
- Avoid CYP2D6 inhibitor (paroxetine) co-administration
72.2.0.3 ð¯ èªææª¢æž¬
- CBZ + äºæŽ² testing? â HLA-B*1502
- Allopurinol + 挢æ? â HLA-B*5801
- Abacavir? â HLA-B*5701
- Clopidogrel CYP? â 2C19 LoF
- Thiopurine äºæŽ² testing? â NUDT15 (+ TPMT)
- CYP2D6 UM + codeine? â äžæ¯ (UM = éå¿«)
- 5-FU testing? â DPYD
- Irinotecan testing? â UGT1A1
- Warfarin 2 genes? â VKORC1, CYP2C9
- G6PD def é¿ 5 è¥? â Primaquine, dapsone, sulfa, nitrofurantoin, methylene blue
- CPIC? â Clinical Pharmacogenetics Implementation Consortium guideline
- Pediatric codeine FDA? â Contraindicated < 12 yo
â ïž AI èçš¿ã